Finances & Transparency
Most of 1Day Sooner’s funding comes from philanthropic grants. None of our funding comes from pharmaceutical companies. We don’t have any financial stake in the studies we choose to promote or the vaccines, drugs, or other therapies they involve.
From our founding in March 2020 to July 2026, 1Day Sooner has received approximately US$12,819,433 in cumulative funding. Grants under $50,000 are grouped for legibility.
Cumulative Funding
Coefficient Giving (formerly Open Philanthropy) has also provided $2,900,000 to 1Day Action, a separately registered 501(c)(4).
We received funding from the FTX Foundation before the revelations of its fraudulent practices and subsequent bankruptcy in November 2022. We proactively decided to return all funding to relevant stakeholders in the FTX bankruptcy proceedings, a process which was concluded in December 2023. These funds, a total of just under $400,000, are not reflected above.
Separately, in April 2026 we received $650,000 directed to 1Day Sooner by Ross Rheingans-Yoo, a former FTX Foundation employee, from the charitable-giving portion of his own compensation. The U.S. Bankruptcy Court for the District of Delaware approved the donation. These funds are included in the “individual donors” category and are distinct from the FTX Foundation grants described above.